In 2026, Fisher & Paykel Healthcare completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
Fisher & Paykel Healthcare has also provided a category-level breakdown for 10 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2026 | 2025 | 2024 | 2023-2019 |
|---|---|---|---|---|
Total Scope 1 | 1,739a | 2,295a | 2,013a | |
Total Scope 2 | ||||
Market-Based | 14,247a | 12,406a | 12,253a | |
Location-Based | 16,729a | 13,232a | 14,293a | |
Unspecified Calculation Method | N/A | N/A | N/A | |
Total Scope 3 | 266,077a | 266,044a | 241,420a | |
Total Scope 1 Revenue Intensity (tCO2e/$M) | 1.3144a | 3.157a | 1.9139a |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2026, the total operational greenhouse gas (GHG) emissions of Fisher & Paykel Healthcare amounted to 18,468 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2025, the total operational greenhouse gas (GHG) emissions of Fisher & Paykel Healthcare increased by 18.94%, suggesting that the company faced challenges in reducing its emissions from its core operations.a
In 2026, the total Scope 1 emissions of Fisher & Paykel Healthcare were 1,739 metric tons of CO₂ equivalent (tCO₂e).a
Since 2020, Fisher & Paykel Healthcare's Scope 1 emissions have decreased by 9.14%, reflecting a declining long-term trend in Scope 1 emissions over time.ab
Compared to the previous year (2025), Fisher & Paykel Healthcare's Scope 1 emissions decreased by 24.23%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.a
In 2026, Fisher & Paykel Healthcare reported Scope 2 greenhouse gas (GHG) emissions of 14,247 tCO₂e using the market-based method and 16,729 tCO₂e using the location-based method.a
Compared to the previous year (2025), Fisher & Paykel Healthcare's Scope 2 emissions (Location-Based) rose by 26.43% in 2026, suggesting that the company faced challenges in reducing emissions from purchased electricity and energya
In 2026, Fisher & Paykel Healthcare reported its Scope 2 emissions using the market-based method and using the location-based method.a
In 2026, Fisher & Paykel Healthcare reported 266,077 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a
The 2026 disclosure of Fisher & Paykel Healthcare includes a breakdown across 10 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2025, demonstrating consistent Scope 3 emissions reporting coverage year over year.a
In 2026, Fisher & Paykel Healthcare reported total Scope 3 emissions of 266,077 metric tons of CO₂ equivalent (tCO₂e).a
Approximately 62.87% of these emissions originated from upstream activities such as purchased goods and capital goods, while 37.13% came from downstream activities like product use, distribution, and end-of-life treatment.a
Since 2020, Fisher & Paykel Healthcare's Scope 3 emissions have decreased by 59.07%, reflecting a declining long-term trend in Scope 3 emissions over time.ab
Compared to the previous year (2025), Fisher & Paykel Healthcare's Scope 3 emissions remained relatively stable, indicating that Fisher & Paykel Healthcare's emissions have plateaued with no significant change in its value chain footprint.a
In 2026, Fisher & Paykel Healthcare reported emissions for 10 out of the 15 Scope 3 categories defined by the GHG Protocol.a
This reflects a high level of granularity and transparency in the company's emissions reporting.
In 2026, the largest contributors to Fisher & Paykel Healthcare's Scope 3 emissions were:a
In 2026, Fisher & Paykel Healthcare reported Scope 1 greenhouse gas (GHG) emissions of 1,739 tCO₂e and total revenues of USD 1,323 millions. This translates into an emissions intensity of 1.31 tCO₂e per millions USD.a
In 2026, Fisher & Paykel Healthcare reported a Scope 1 emissions intensity of 1.31 tCO₂e per millions USD. Compared to the peer group median of 4.92, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a
In 2026, Fisher & Paykel Healthcare ranked 3 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a
This places Fisher & Paykel Healthcare among the top performers, with one of the lowest emissions intensities relative to peers.a
In 2026, Fisher & Paykel Healthcare reported a total carbon footprint of 284,545 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 1.06% increase compared to 2025, suggesting a rise in emissions across its operations or value chain.a
The largest contributor to Fisher & Paykel Healthcare's total carbon footprint was Scope 3 emissions, accounting for 93.51% of the company's total carbon footprint, followed by Scope 2 emissions at 5.88%.a